Showing results (1-10 of 138) with videos related to
Sort By:
Pageof 14
International Journal of Hematology|May 18, 2022
Novel immunotherapies in multiple myelomaKen Ohmine, Ryosuke UchiboriScientific Reports|June 3, 2026
Soluble PD-L1-secreting umbilical cord-derived mesenchymal stromal cells transiently attenuate established xenogeneic T cell activation in vivoRyosuke Uchibori, Ken Ohmine, Keiya OzawaCancer Science|December 1, 2025
Trichostatin A Sensitizes Tumor Cells to Apoptosis Induced by Soluble Trimeric TRAIL-Expressing Human Mesenchymal Stromal CellsRyosuke Uchibori, Ken Ohmine, Keiya OzawaInternational Journal of Hematology|March 1, 2014
Cancer gene therapy using mesenchymal stem cellsRyosuke Uchibori, Tomonori Tsukahara, Ken Ohmine, et al.Human Gene Therapy|May 15, 2025
BCMA-CAR Therapy for Multiple Myeloma in NOG Mice Prevents the Progression of Anemia and Bone LesionsRyosuke Uchibori, Ken Ohmine, Takeshi Teruya, et al.Molecular Therapy Oncolytics|January 22, 2019
Functional Analysis of an Inducible Promoter Driven by Activation Signals from a Chimeric Antigen ReceptorRyosuke Uchibori, Takeshi Teruya, Hiroyuki Ido, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 3, 2024
[Challenges and strategies for improving efficacy in CAR-T therapy]Ryosuke Uchibori[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 7, 2018
[Clinical development of CAR-T therapy for refractory multiple myeloma]Ken OhmineEuropean Journal of Haematology|May 24, 2023
Cytotoxicity and exhaustion markers of chimeric antigen receptor T cells targeting BCMA in multiple myeloma cell lines between patients and healthy donorsSomsak Prasongtanakij, Sarinthip Preedagasamzin, Bunyada Jittorntrum, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 13, 2016
Adoptive immunotherapy utilizing anti-CD19 chimeric antigen receptor T-cells for B-cell malignanciesIekuni Oh, Yukiko Oh, Ken OhminePageof 14